CollPlant Biotechnologies (CLGN) EBITDA Margin (2018 - 2025)
CollPlant Biotechnologies' EBITDA Margin came in at -4890.00% for the quarter ended Dec 31, 2025, down 2614.39 percentage points from -2275.61% a year earlier and down 625.06 percentage points from the prior quarter.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) EBITDA Margin (2018 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, CollPlant Biotechnologies' EBITDA Margin was -445.85%, up 2702.31 percentage points from the prior year.
- EBITDA Margin carries a five-year change of -365.37 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, EBITDA Margin was -3148.16% in the year ended Dec 31, 2024 (-3089.66 pp), -58.49% in the year ended Dec 31, 2023 (+5299.70 pp), -5358.19% in the year ended Dec 31, 2022 (-5363.55 pp) and 5.36% in the year ended Dec 31, 2021 (+85.84 pp).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly EBITDA Margin since the quarter ended Sep 30, 2024.
- Year-over-year, EBITDA Margin increased in four of the last seven quarters, with an average year-over-year change of +1169.36 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in the quarter ended Sep 30, 2025 (a gain of 102910.06 percentage points), and the weakest in the quarter ended Sep 30, 2024 (a drop of 97105.23 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | CollPlant Biotechnologies | 4.95 Mn | 4.95 Mn | -243,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4,890.00% |
| Sep 30, 2025 | -4,264.94% |
| Jun 30, 2025 | 1,903.35% |
| Dec 31, 2024 | -2,275.61% |
| Sep 30, 2024 | -107,175.00% |
| Jun 30, 2024 | 1,874.30% |
| Mar 31, 2024 | 4,703.06% |
| Dec 31, 2023 | -1,600.00% |
| Sep 30, 2023 | -10,069.77% |
| Jun 30, 2023 | 58.36% |
| Mar 31, 2023 | 877.37% |
| Dec 31, 2022 | -7,555.17% |
| Sep 30, 2022 | -3,841.28% |
| Jun 30, 2022 | -5,945.45% |
| Dec 31, 2021 | -1,154.84% |
| Sep 30, 2021 | -2,069.29% |
| Jun 30, 2021 | -417.37% |
| Mar 31, 2021 | 70.34% |
| Dec 31, 2020 | -457.27% |
| Sep 30, 2020 | 21.72% |
API Access
CollPlant Biotechnologies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();